Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1702645

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1702645

Antacids Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2990
PDF (5 User License + Excel)
USD 3490
PDF (Corporate License)
USD 3990

Add to Cart

Antacids Market Trends & Summary

Tea Market is expected to reach US$ 10.11 billion by 2033 from US$ 7.15 billion in 2024, with a CAGR of 3.93% from 2025 to 2033. The market is expanding primarily due to the increase of retail pharmacies, the growing number of patients suffering from gastroesophageal reflux disease (GERD), and the desire for over-the-counter medications.

The report Antacids Global Market covers by Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents) Formulation Type (Tablets, Liquid, Powder, Others) Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) Countries and Company Analysis, 2025-2033.

Global Antacids Industry Overview

Antacids are drugs used to counteract too much stomach acid. They provide alleviation for symptoms such as acid reflux, indigestion, and heartburn. By raising the pH of the stomach's contents, antacids reduce acidity and ease the discomfort that comes with high stomach acid levels, which are acidic. Antacids are a practical way for people to self-treat minor symptoms because they are available without a prescription. They are commonly accessible over-the-counter in a variety of forms, such as chewable pills, liquids, and tablets. They provide immediate symptom relief. Antacids have several advantages, such as their quick effectiveness, availability over-the-counter, and variety of formulations to suit personal tastes. For treating the temporary symptoms of excessive stomach acid, antacids are easily obtained and efficient solutions. They currently come in a variety of forms and are effective in terms of flavor and taste.

A 2022 National Institutes of Health (NIH) study found that 783.95 million persons worldwide received a GERD diagnosis in 2019. Between 1990 and 2019, the overall number of years lived with disability (YLD) increased by 77.19%, while the total number of prevalent cases and incident cases climbed by 77.53% and 74.79%, respectively.

Additionally, the need for antacids is being driven by e-commerce, and because of the convenience they provide, online retail channels are expanding quickly. Therefore, the market's overall growth is being positively impacted by the rising popularity of e-commerce and the expanding number of online healthcare providers.

The adverse consequences of antacid use are one of the main obstacles facing the antacid market. Common antacid adverse effects include dose-dependent rebound hyperacidity and the milk-alkali syndrome. Furthermore, adverse side effects such osteomalacia, hypophosphatemia, constipation, and metal poisoning can occur from antacids that include aluminum hydroxide. The market's expansion is expected to be constrained by the growing concerns regarding these negative effects.

Growth Drivers for the Antacids Market

Shifting demography as a result of the growing number of elderly people

Antacids are becoming more and more important to the elderly due to their ability to quickly relieve acidity. As a result, they frequently purchase or ingest antacids to treat these stomach problems. One could argue that antacid sales globally may be higher in countries with higher rates of aging populations. One in six people will be 60 years of age or older by 2030 and 2050, according to 2022 World Health Organization (WHO) research. Additionally, there will be 2.1 billion people over 60 in the world, up from 1.4 billion in 2020.

The rising incidence of acidity and heartburn

Heartburn and indigestion are becoming more common as a result of dietary and lifestyle changes linked to irregular eating habits and increased consumption of spicy or acidic foods. Factors like obesity and other contemporary lifestyle choices are to blame for the increase in acid-related problems, such as gastroesophageal reflux disease (GERD). Digestive issues are made worse by stress, sedentary lifestyles, and unpredictable sleep patterns. Antacids are often used for self-treatment since they are readily available over-the-counter. Thus, given the changes in lifestyle, the rising incidence of indigestion and related disorders will support the expansion of the worldwide antacid market.

Rising Stress and Anxiety Levels

An important factor in the rising need for antacids is the rise in stress and anxiety levels. By raising the production of stomach acid, stress and emotional discomfort can impair digestive health and cause common problems like acid reflux, heartburn, and indigestion. There is a greater dependence on over-the-counter antacid drugs for treatment as more people suffer from these symptoms as a result of contemporary stressors. Antacids are a handy choice for people looking for immediate symptom relief without a prescription because they are readily available at pharmacies and supermarkets. The market for antacids is expanding due to the rise in self-medication brought on by growing awareness of digestive health. The demand for antacid solutions is predicted to climb further as the number of digestive problems linked to stress continues to rise.

Challenges in the Antacids Market

Side Effects and Overuse Concerns

Constipation, diarrhea, and an imbalance in stomach acidity are just a few of the adverse effects that can result from using antacids too frequently or excessively. While overuse of antacids, especially those with calcium or aluminum, might result in constipation, tablets with magnesium can cause diarrhea. Additionally, prolonged use might upset the stomach's natural acid-base balance, which can impact nutrient absorption and digestion. Furthermore, an excessive dependence on antacids may conceal underlying illnesses including ulcers, GERD, or other gastrointestinal diseases. This may postpone an accurate diagnosis and course of treatment, which over time may result in more serious health problems. In order to prevent long-term issues, users are therefore encouraged to use antacids carefully and consult a doctor for recurrent problems.

Competition from Alternative Remedies

The market for conventional antacids is facing competition from the rising popularity of home and natural therapies. To treat heartburn and indigestion symptoms, more customers are increasingly using herbal remedies like peppermint, chamomile, or ginger in addition to dietary adjustments. When compared to pharmaceutical antacids, these substitutes are frequently thought to be safer, more natural, and less likely to cause negative side effects. Furthermore, better dietary practices and stress reduction are two lifestyle changes that are increasingly being used to treat digestive problems. Some consumers are turning away from traditional antacid treatments as awareness of these alternative therapies grows, putting pressure on pharmaceutical businesses to compete. Long-term growth potential in the antacids market may be constrained by this tendency.

United States Antacids Market

The market for antacids in the US is steadily expanding due to a rise in gastrointestinal conditions such heartburn, acid reflux, and indigestion. More consumers are using over-the-counter antacid medicines for immediate and efficient relief as digestive health becomes more well recognized. To accommodate different consumer preferences, the market is further supported by a broad variety of antacid formulations, such as chewable pills, liquids, and effervescent solutions. The increasing need for antacids is also a result of sedentary lifestyles, poor diets, and stress. Long-term market development, however, can be impacted by worries about antacid misuse and other adverse effects. Despite this, antacids are becoming more widely available in pharmacies and supermarkets, which guarantees high market demand and accessibility.

Germany Antacids Market

The rising incidence of gastrointestinal conditions such heartburn, acid reflux, and indigestion, especially among the elderly population, is driving growth in the German antacid industry. Due to increased awareness of digestive health and the ease of accessing products, consumers are increasingly resorting to over-the-counter antacids for quick relief. A robust healthcare system and the growing popularity of self-medication are factors that support the market. The market is also growing as a result of improvements in antacid formulations, such as more practical and efficient administration systems including chewable tablets and effervescent powders. However, issues may arise due to worries about antacid misuse and possible adverse consequences. In spite of this, antacid demand is still high in Germany due to increased consumer health consciousness and easier access to medical supplies.

India Antacids Market

The growing incidence of gastrointestinal conditions like heartburn, acid reflux, and indigestion is driving significant growth in the Indian antacid industry. The nation's antacid product demand is rising as a result of stress, poor diets, and changes in lifestyle. More people are using over-the-counter antacids for immediate relief due to the big population and growing awareness of digestive health. Market expansion is also fueled by the availability of different formulations, including beverages, effervescent pills, and chewable tablets. Antacids are also simpler to find in pharmacies and retail stores as the middle class grows and healthcare infrastructure advances. The Indian antacid industry is anticipated to keep expanding as consumer health consciousness rises, despite obstacles including limited knowledge in rural areas.

United Arab Emirates Antacids Market

In the United Arab Emirates (UAE), the market for antacids is growing as a result of an increase in gastrointestinal conditions such heartburn, acid reflux, and indigestion brought on by stress, poor diets, and sedentary lifestyles. More people are turning to over-the-counter antacids for relief as digestive health knowledge rises. The market's expansion is further supported by the UAE's sophisticated healthcare system and high purchasing power, which offer a large range of antacid formulations, such as chewable pills, liquids, and effervescent products. Demand is also driven by consumers' growing appetite for quick-fixing, convenient solutions. Despite ongoing worries about abuse and possible adverse consequences, the industry is expanding because to rising demand, especially from urban populations, for easily accessible digestive health remedies.

Antacids Market Segments

Drug Class - Market in 4 Viewpoints -

1. Proton Pump Inhibitors

2. H2 Antagonist

3. Acid Neutralizers

4. Pro-Motility Agents

Formulation Type - Market in 4 Viewpoints -

1. Tablets

2. Liquid

3. Powder

4. Others

Distribution Channel - Market in 3 Viewpoints -

1. Retail Pharmacy

2. Hospital Pharmacy

3. Online Pharmacy

Country

North America

1. United States

2. Canada

Europe

1. France

2. Germany

3. Italy

4. Spain

5. United Kingdom

6. Belgium

7. Netherlands

8. Turkey

Asia Pacific

1. China

2. Japan

3. India

4. Australia

5. South Korea

6. Thailand

7. Malaysia

8. Indonesia

9. New Zealand

Latin America

1. Brazil

2. Mexico

3. Argentina

Middle East & Africa

1. South Africa

2. Saudi Arabia

3. United Arab Emirates

Company Insights:

  • Overviews
  • Key Persons
  • Recent Developments
  • Revenue

Company Analysis:

1. Abbott Laboratories

2. AstraZeneca plc

3. Bayer AG

4. Boehringer Ingelheim International GmbH

5. Dr. Reddy's Laboratories Ltd.

6. GlaxoSmithKline plc

7. Johnson & Johnson

8. Pfizer Inc.

9. Procter & Gamble Company

10. Sanofi S.A.

11. Sun Pharmaceutical Industries Ltd.

12. Takeda Pharmaceutical Company Limited

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Antacids Market

6. Market Share

  • 6.1 Drug Class
  • 6.2 Formulation Type
  • 6.3 Distribution Channel
  • 6.4 Country

7. Drug Class

  • 7.1 Proton Pump Inhibitors
  • 7.2 H2 Antagonist
  • 7.3 Acid Neutralizers
  • 7.4 Pro-Motility Agents

8. Formulation Type

  • 8.1 Tablets
  • 8.2 Liquid
  • 8.3 Powder
  • 8.4 Others

9. Distribution Channel

  • 9.1 Retail Pharmacy
  • 9.2 Hospital Pharmacy
  • 9.3 Online Pharmacy

10. By Country - Global Antacids Market

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherlands
    • 10.2.8 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 Australia
    • 10.3.5 South Korea
    • 10.3.6 Thailand
    • 10.3.7 Malaysia
    • 10.3.8 Indonesia
    • 10.3.9 New Zealand
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 South Africa
    • 10.5.2 Saudi Arabia
    • 10.5.3 UAE

11. Porter's Five Analysis

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Company Analysis

  • 13.1 Abbott Laboratories
    • 13.1.1 Overview
    • 13.1.2 Recent Developments
    • 13.1.3 Revenue
  • 13.2 AstraZeneca plc
    • 13.2.1 Overview
    • 13.2.2 Recent Developments
    • 13.2.3 Revenue
  • 13.3 Bayer AG
    • 13.3.1 Overview
    • 13.3.2 Recent Developments
    • 13.3.3 Revenue
  • 13.4 Boehringer Ingelheim International GmbH
    • 13.4.1 Overview
    • 13.4.2 Recent Developments
    • 13.4.3 Revenue
  • 13.5 Dr. Reddy's Laboratories Ltd.
    • 13.5.1 Overview
    • 13.5.2 Recent Developments
    • 13.5.3 Revenue
  • 13.6 GlaxoSmithKline plc
    • 13.6.1 Overview
    • 13.6.2 Recent Developments
    • 13.6.3 Revenue
  • 13.7 Johnson & Johnson
    • 13.7.1 Overview
    • 13.7.2 Recent Developments
    • 13.7.3 Revenue
  • 13.8 Pfizer Inc.
    • 13.8.1 Overview
    • 13.8.2 Recent Developments
    • 13.8.3 Revenue
  • 13.9 Procter & Gamble Company
    • 13.9.1 Overview
    • 13.9.2 Recent Developments
    • 13.9.3 Revenue
  • 13.10 Sanofi S.A.
    • 13.10.1 Overview
    • 13.10.2 Recent Developments
    • 13.10.3 Revenue
  • 13.11 Sun Pharmaceutical Industries Ltd.
    • 13.11.1 Overview
    • 13.11.2 Recent Developments
    • 13.11.3 Revenue
  • 13.12 Takeda Pharmaceutical Company Limited
    • 13.12.1 Overview
    • 13.12.2 Recent Developments
    • 13.12.3 Revenue
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!